GENAIZ is a federated learning platform for the life sciences industry that aims to improve patient outcomes and foster innovation by enabling the sharing, monetization, and access of data, as well as the implementation of AI solutions. The platform offers three primary machine learning algorithms - RefAI, QualitAIx, and ClAInix - each designed to streamline and enhance different aspects of data processing and analysis within the industry. These algorithms are reportedly over 1000x faster than conventional approaches, offering a 2.3x increase in accuracy compared to manual labor and promising results in just 3 clicks.
Founded in 2016 and headquartered in Canada, GENAIZ is positioned at the intersection of AI, IT, and Machine Learning industries. While specific details about the last investment and investors are currently unavailable, the company's mission to empower the life sciences industry with data-driven insights and its innovative approach to leveraging AI solutions make it a notable player in the sector.